Treatment of bone metastases of prostate cancer with strontium-89 chloride: Efficacy in relation to the degree of bone involvement

European Journal of Nuclear Medicine

Volumn 27, Issue 10, 2000, Pages 1487-1493

  Kraeber Bodere, F ^a   Campion, L ^a   Rousseau, C ^a   Bourdin, S ^a   Chatal, J F ^a   Resche, I ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

Internal radiotherapy; Metastases; Pain; Prostate cancer; Strontium 89

Indexed keywords

STRONTIUM 89; TECHNETIUM 99M;

ADULT; AGED; ANALGESIA; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PROSTATE CANCER; QUALITY OF LIFE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALGESIA; ANALGESICS; BONE NEOPLASMS; HUMAN; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGE; PAIN; PALLIATIVE CARE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; STRONTIUM; STRONTIUM RADIOISOTOPES;

EID: 0033774529     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000315     Document Type: Article

References (29)

1. Le cancer de la prostate localise ou metastatique: Revue de nouvelles modalites de prise en charge
2. The treatment of cancer pain
3. Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate
4. Sr-89 therapy: Strontium plasma clearance in disseminated prostatic carcinoma
5. 89Sr radionuclide therapy
6. Strontium-89 therapy: Measurement of absorbed dose to skeletal metastases
7. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma
8. Strontium-89: Treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone
9. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy
10. An evaluation of the safety and efficacy of treatment with strontium-89 in patients who have previously received wide field radiotherapy
11. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer
12. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
13. Strontium-89 therapy for the pain of osseous metastases
14. Radiotoxicity after strontium-89 therapy for bone metastases using the micronucleus assay
15. Radioimmunotherapy of patients with small-volume tumors with iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2
16. Radionuclide therapy of intractable bone pain: Emphasis on strontium-89
17. Clinical experience with strontium-89 in prostatic and breast cancer patients
18. Utilisation du samarium-153-EDTMP dans le traitement des metastases osseuses douloureuses
19. Disseminated intravascular coagulation in a patient with metastatic prostate cancer: Fatal outcome following strontium-89 therapy
20. Coagulopathy in the prostate cancer patient: Prevalence and clinical relevance
21. Untreated prostatic carcinoma is not associated with frequent thrombohemorrhagic disorders
22. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: Preliminary report of a multicenter trial
23. Strontium-89 (Metastron) in the treatment of prostate cancer metastatic to bone
24. Endossale isotopen-therapie maligner skeletter-krankungen
25. Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89
26. Determinants of tumor blood flow: A review
27. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
28. Les traitements de la douleur du cancer prostatique et des metastases osseuses
29. Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: A preliminary report